Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStm Grp. Regulatory News (STM)

Share Price Information for Stm Grp. (STM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 55.00
Ask: 60.00
Change: 0.00 (0.00%)
Spread: 5.00 (9.091%)
Open: 57.50
High: 57.50
Low: 57.50
Prev. Close: 57.50
STM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CLN Update & Issue of Equity

16 Apr 2015 07:00

RNS Number : 3611K
STM Group PLC
16 April 2015
 

 

 16 April 2015

 

 

STM Group Plc

("STM" or "the Company")

Loan Note Conversion Update and Issue of Equity

 

STM Group Plc (AIM: STM), the multi-jurisdictional financial services group, announces that the Company has received conversion notices (the "Conversion Notices") in respect of 155 convertible loan notes each with a face value of £10,000 ("Convertible Loan Notes"), the issue of which was previously announced on 15 May 2014.

 

To date, 70 of the Convertible Loan Notes with a value of £700,000 have been repaid by the Company. The remaining 30 unconverted Convertible Loan Notes will run to term and be repaid by the Company in March 2016.

 

Pursuant to the Conversion Notices, the Company will issue 5,961,538 new ordinary shares (the "Conversion Shares") at a price of 26p per Conversion Share. Application will be made for the Conversion Shares to be admitted to trading on the AIM Market of the London Stock Exchange ("Admission") and it is expected that such Admission will occur and dealings will commence on or before 30 April 2015.

 

Within the Conversion Notices received, Clifton Participations Inc ("Clifton"), of which Alan Kentish, STM's Director of Business & Product Development is a beneficial owner, will convert 32.5 Convertible Loan Notes with a value of £325,000. Accordingly, Clifton will be issued 1,250,000 Conversion Shares. Following this issue, which is subject to regulatory approval, Alan Kentish will own 7,218,817 Ordinary Shares in his personal name and through his beneficial holding in Clifton Participants Inc., representing 12.15% of the Company's total issued share capital and voting rights following Admission. In addition, Louise Kentish, Alan Kentish's wife, holds, as Trustee of the Focus Trust, 1,100,000 Ordinary Shares equating to 1.85% of the Company's total issued share capital and voting rights following Admission. Neither Alan Kentish nor Louise Kentish have a beneficial interest in the shares held by the Focus Trust.

 

Following Admission, the total number of ordinary shares in issue with voting rights will be 59,408,087 with each such ordinary share carrying the right to one vote. There are no shares held in treasury. The figure of 59,408,087 may be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest, or a change to their interest, in STM under the FCA's Disclosure and Transparency Rules.

 

Commenting on the Loan Note conversion, Colin Porter, Chief Executive at STM, said:

 

"The extent of the Convertible Loan Note holders wishing to convert into equity in STM demonstrates considerable confidence in the business; particularly given that one of those converting is our Director of Business & Product Development, Alan Kentish.

 

"Additionally, this reduces our structured borrowing to £300,000 which will further enhance profitability for 2015."

 

 

For further information, please contact:

STM Group Plc

www.stmgroupplc.com

Colin Porter, Chief Executive Officer

colin.porter@stmgroupplc.com

Tel: +350 200 42686

 

 

 

Therese Neish, Chief Financial Officer

therese.neish@stmgroupplc.com

 Tel: +350 200 42686

 

 

 

Alan Kentish, Director of Business and Product Development

alan.kentish@stmgroupplc.com

Tel: +350 200 42686

 

 

finnCap

www.finncap.com

Charlotte Stranner / Christopher Raggett - Corporate Finance

Mia Gardner - Corporate Broking

Tel: +44 (0) 20 7220 0500

 

 

Walbrook PR

www.walbrookpr.com  

Tom Cooper / Paul Vann

Tel: +44 (0) 117 985 8989

 

Mob: +44 (0) 797 122 1972

 

tom.cooper@walbrookpr.com

 

 

Notes to editors:

 

STM is a multi jurisdictional financial services group which is listed on the AIM Market of the London Stock Exchange. The Group specialises in the administration of assets for international clients in relation to retirement, estate and succession planning and wealth structuring.

 

Today, STM has operations in Gibraltar, Spain, Jersey, Malta and Cyprus. The Group is looking to expand through the development of additional products and services that its ever more sophisticated clients demand. STM has, for example, incorporated a Gibraltar Life Insurance Company, STM Life plc, which provides life insurance bonds - wrappers in which a variety of investments, including investment funds, can be held. STM has developed a specialist international pensions division which specialises in Qualifying Recognised Overseas Pension Schemes (QROPS), Qualifying Non UK Pension Schemes (QNUPS) and Employer Funded Retirement Benefit Schemes (EFRBS).

Further information on STM Group can be found at www.stmgroupplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUVOWRVWASAAR
Date   Source Headline
4th May 20237:00 amRNSUpdate re Results and Directorate Change
3rd Apr 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSDirectorate Change - NED Appointment
18th Jan 20237:00 amRNSTrading Statement
9th Nov 20227:00 amRNSChange of Auditor
3rd Oct 20227:00 amRNSAppointment of Interim Chief Financial Officer
14th Sep 20227:00 amRNSInterim Results & Investor Presentation
1st Sep 20227:00 amRNSAcq Completion, Trading Update, Chair Appt, NoR
4th Aug 20222:15 pmRNSResult of AGM
4th Aug 20227:00 amRNSBoard Changes and Trading Update
26th Jul 20227:00 amRNSAcquisition of SIPP & SSAS portfolio
6th Jul 202211:47 amRNSAnnual Report and Accounts and Notice of AGM
10th Jun 20227:00 amRNSChange of Registered Office
8th Jun 20227:00 amRNSFinal Results, Investor Presentation, Board Change
6th Jun 20227:00 amRNSNotice of Results & Investor Presentation
11th Apr 20227:00 amRNSUpdate on appeal of Adams v Carey case
24th Mar 20227:00 amRNSRescheduling of Final Results announcement date
31st Jan 20227:00 amRNSTrading Update, Board Change & Notice of Results
25th Jan 202210:31 amRNSHolding(s) in Company
5th Jan 20223:24 pmRNSHolding(s) in Company
3rd Dec 202111:14 amRNSHolding(s) in Company
3rd Dec 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSTrading Update
1st Nov 202110:47 amRNSHolding(s) in Company
1st Oct 20217:00 amRNSBoard Changes
28th Sep 202110:15 amRNSHolding(s) in Company
20th Sep 202110:46 amRNSHolding(s) in Company
14th Sep 20217:00 amRNSInterim Results & Investor Presentation
12th Aug 20217:00 amRNSTrading Update, Notice of Results & Investor Pres
24th Jun 202111:00 amRNSResult of AGM
24th Jun 20217:00 amRNSAGM Statement
1st Jun 202112:01 pmRNSAnnual Report and Accounts and Notice of AGM
17th May 20217:00 amRNSInvestor Presentation
12th May 20211:40 pmRNSHolding(s) in Company
11th May 20217:00 amRNSFinal Results
10th May 20217:00 amRNSSale of Jersey CTS Business
4th May 202111:45 amRNSHolding(s) in Company
29th Apr 202110:50 amRNSAppeal of Adams v Carey case
16th Apr 20217:00 amRNSDate Change for Results Announcement
1st Apr 202110:57 amRNSAppeal Judgment in Adams v Carey case
24th Mar 20217:00 amRNSSale of Gibraltar CTS & Tax businesses
3rd Feb 20217:00 amRNSTrading Update & Directorate Change
3rd Dec 20204:42 pmRNSHolding(s) in Company
30th Nov 20207:00 amRNSTrading Update
10th Nov 20204:10 pmRNSHolding(s) in Company
6th Nov 20207:00 amRNS£5.5m Credit Facility To Fund M&A Growth Strategy
4th Nov 20207:00 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSTrading Update
21st Sep 20207:00 amRNSAdams V Carey Update
8th Sep 20207:00 amRNSHalf-year Report & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.